Inducing unresponsiveness in allopeptide specific T cells: are altered peptide ligands the answer?
Jones
N D
ND
Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, UK.
D006084:Graft Rejection / Q000276:immunology; D015789:HLA-A2 Antigen / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy; D007519:Isoantigens / Q000276:immunology*; D016030:Kidney Transplantation / Q000276:immunology*; D008285:Major Histocompatibility Complex; D010446:Peptide Fragments / Q000276:immunology*; D010455:Peptides / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology*
D015789:HLA-A2 Antigen; D007519:Isoantigens; D010446:Peptide Fragments; D010455:Peptides